Abstract
The complex pathogenesis of temporal lobe epilepsy includes neuronal and glial pathology, synaptic reorganization, and an immune response. However, the spatio-temporal pattern of structural changes in the brain that provide a substrate for seizure generation and modulate the seizure phenotype is yet to be completely elucidated. We used quantitative magnetic resonance imaging (MRI) to study structural changes triggered by status epilepticus (SE) and their association with epileptogenesis and with activation of complement component 3 (C3). SE was induced by injection of pilocarpine in CD1 mice. Quantitative diffusion-weighted imaging and T2 relaxometry was performed using a 16.4-Tesla MRI scanner at 3 h and 1, 2, 7, 14, 28, 35, and 49 days post-SE. Following longitudinal MRI examinations, spontaneous recurrent seizures and interictal spikes were quantified using continuous video-EEG monitoring. Immunohistochemical analysis of C3 expression was performed at 48 h, 7 days, and 4 months post-SE. MRI changes were dynamic, reflecting different outcomes in relation to the development of epilepsy. Apparent diffusion coefficient changes in the hippocampus at 7 days post-SE correlated with the severity of the evolving epilepsy. C3 activation was found in all stages of epileptogenesis within the areas with significant MRI changes and correlated with the severity of epileptic condition.
Similar content being viewed by others
Abbreviations
- TLE:
-
Temporal lobe epilepsy
- SE:
-
Status epilepticus
- C3:
-
Complement component 3
- MRI:
-
Magnetic resonance imaging
- SRS:
-
Spontaneous recurrent seizures
- DWI:
-
Diffusion-weighted imaging
- NS:
-
No seizures
- CN:
-
Control
- ADC:
-
Apparent diffusion coefficient
- T2:
-
Apparent transverse relaxation time
- CA1:
-
Cornu Ammonis 1 region of the hippocampus proper
- gcl:
-
Granule cell layer
- H:
-
Hilus of the dentate gyrus
References
Abbott NJ, Khan EU, Rollinson CMS, Reichel A, Janigro D, Dombrowski SM, Dobbie MS, Begley DJ (2002) Drug resistance in epilepsy: the role of the blood-brain barrier. Norvatis Found Symp 243:38–47 discussion 47–53, 180–185
Alexander JJ, Anderson AJ, Barnum SR, Stevens B, Tenner AJ (2008) The complement cascade: Yin-Yang in neuroinflammation—neuro-protection and -degeneration. J Neurochem 107(5):1169–1187. doi:10.1111/j.1471-4159.2008.05668.x
Aronica E, Boer K, van Vliet EA, Redeker S, Baayen JC, Spliet WGM, van Rijen PC, Troost D, da Silva FHL, Wadman WJ, Gorter JA (2007) Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 26(3):497–511. doi:10.1016/j.nbd.2007.01.015
Barnum SR, Jones JL (1995) Differential regulation of C3 gene expression in human astroglioma cells by interferon-gamma and interleukin-1 beta. Neurosci Lett 197(2):121–124. doi:10.1016/0304-3940(95)11923-k
Bernasconi N, Duchesne S, Janke A, Lerch J, Collins DL, Bernasconi A (2004) Whole-brain voxel-based statistical analysis of gray alter and white matter in temporal lobe epilepsy. Neuroimage 23(2):717–723. doi:10.1016/j.neuroimage.2004.06.015
Bonilha L, Kobayashi E, Rorden C, Cendes F, Li LM (2003) Medial temporal lobe atrophy in patients with refractory temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 74(12):1627–1630. doi:10.1136/jnnp.74.12.1627
Bonilha L, Nesland T, Martz GU, Joseph JE, Spampinato MV, Edwards JC, Tabesh A (2012) Medial temporal lobe epilepsy is associated with neuronal fibre loss and paradoxical increase in structural connectivity of limbic structures. J Neurol Neurosurg Psychiatry 83(9):903–909. doi:10.1136/jnnp-2012-302476
Borges K, Gearing M, McDermott DL, Smith AB, Almonte AG, Wainer BH, Dingledine R (2003) Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp Neurol 182(1):21–34. doi:10.1016/s0014-4886(03)00086-4
Borges K, McDermott D, Irier H, Smith Y, Dingledine R (2006) Degeneration and proliferation of astrocytes in the mouse dentate gyrus after pilocarpine-induced status epilepticus. Exp Neurol 201(2):416–427. doi:10.1016/j.expneurol.2006.04.031
Briellmann RS, Kalnins RM, Berkovic SF, Jackson GD (2002) Hippocampal pathology in refractory temporal lobe epilepsy—T2-weighted signal change reflects dentate gliosis. Neurology 58(2):265–271
Buckmaster PS (2004) Laboratory animal models of temporal lobe epilepsy. Comp Med 54(5):473–485
Cavalheiro EA, Santos NF, Priel MR (1996) The pilocarpine model of epilepsy in mice. Epilepsia 37(10):1015–1019. doi:10.1111/j.1528-1157.1996.tb00541.x
Chen J, Larionov S, Hoerold N, Ullmann C, Elger CE, Schramm J, Becker AJ (2005) Expression analysis of metabotropic glutamate receptors I and III in mouse strains with different susceptibility to experimental temporal lobe epilepsy. Neurosci Lett 375(3):192–197. doi:10.1016/j.neulet.2004.11.008
Choy M, Cheung KK, Thomas DL, Gadian DG, Lythgoe MF, Scott RC (2010a) Quantitative MRI predicts status epilepticus-induced hippocampal injury in the lithium-pilocarpine rat model. Epilepsy Res 88(2–3):221–230. doi:10.1016/j.eplepsyres.2009.11.013
Choy M, Wells JA, Thomas DL, Gadian DG, Scott RC, Lythgoe MF (2010b) Cerebral blood flow changes during pilocarpine-induced status epilepticus activity in the rat hippocampus. Exp Neurol 225(1):196–201. doi:10.1016/j.expneurol.2010.06.015
Clemens Z, Janszky J, Clemens M, Szucs A, Halasz P (2005) Factors affecting spiking related to sleep and wake states in temporal lobe epilepsy (TLE). Seizure 14(1):52–57. doi:10.1016/j.seizure.2004.09.003
Curia G, Longo D, Biagini G, Jones RSG, Avoli M (2008) The pilocarpine model of temporal lobe epilepsy. J Neurosci Methods 172(2):143–157. doi:10.1016/j.jneumeth.2008.04.019
de Lanerolle NC, Lee T-S, Spencer DD (2010) Astrocytes and Epilepsy. Neurotherapeutics 7(4):424–438
Dudek FE, Staley KJ (2011) The time course of acquired epilepsy: implications for therapeutic intervention to suppress epileptogenesis. Neurosci Lett 497(3):240–246. doi:10.1016/j.neulet.2011.03.071
Duffy BA, Choy M, Riegler J, Wells JA, Anthony DC, Scott RC, Lythgoe MF (2012) Imaging seizure-induced inflammation using an antibody targeted iron oxide contrast agent. Neuroimage 60(2):1149–1155. doi:10.1016/j.neuroimage.2012.01.048
Eng J (2006) ROC analysis: web-based calculator for ROC curves. Johns Hopkins University http://www.rad.jhmi.edu/jeng/javarad/roc/JROCFITi.html. Accessed Jan 30 2013
Engel J Jr (2011) Biomarkers in epilepsy: introduction. Biomarkers Med 5(5):537–544. doi:10.2217/bmm.11.62
Engel J, Williamson PD, Wieser HG (2008) Mesial temporal lobe epilepsy with hippocampal sclerosis. In: Engel J, Pedley TA (eds) Epilepsy: a comprehensive textbook, 2nd edn. Lippincott-Raven, Philadelphia, pp 2479–2486
Fabene PF, Marzola P, Sbarbati A, Bentivoglio M (2003) Magnetic resonance imaging of changes elicited by status epilepticus in the rat brain: diffusion-weighted and T2-weighted images, regional blood volume maps, and direct correlation with tissue and cell damage. Neuroimage 18(2):375–389. doi:10.1016/s1053-8119(02)00025-3
Fabene PF, Weiczner R, Marzola P, Nicolato E, Calderan L, Andrioli A, Farkas E, Sule Z, Mihaly A, Sbarbati A (2006) Structural and functional MRI following 4-aminopyridine-induced seizures: a comparative imaging and anatomical study. Neurobiol Dis 21(1):80–89. doi:10.1016/j.nbd.2005.06.013
French JA, Williamson PD, Thadani VM, Darcey TM, Mattson RH, Spencer SS, Spencer DD (1993) Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol 34(6):774–780. doi:10.1002/ana.410340604
Genovese CR, Lazar NA, Nichols T (2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15(4):870–878. doi:10.1006/nimg.2001.1037
Herman ST (2006) Clinical trials for prevention of epileptogenesis. Epilepsy Res 68(1):35–38. doi:10.1016/j.eplepsyres.2005.09.015
Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins O, Seiffert E, Heinemann U, Friedman A (2007) TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130:535–547. doi:10.1093/brain/awl317
Jackson GD, Berkovic SF, Tress BM, Kalnins RM, Fabinyi GCA, Bladin PF (1990) Hippocampal sclerosis can be reliably detected by magnetic-resonance-imaging. Neurology 40(12):1869–1875
Jackson GD, Berkovic SF, Duncan JS, Connelly A (1993) Optimizing the diagnosis of hippocampal sclerosis using MR imaging. Am J Neuroradiol 14(3):753–762
Jamali S, Bartolomei F, Robaglia-Schlupp A, Massacrier A, Peragut JC, Regis J, Dufour H, Ravid R, Roll P, Pereira S, Royer B, Roeckel-Trevisiol N, Fontaine M, Guye M, Boucraut J, Chauvel P, Cau P, Szepetowski P (2006) Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex. Brain 129:625–641. doi:10.1093/brain/awl001
Jamali S, Salzmann A, Perroud N, Ponsole-Lenfant M, Cillario J, Roll P, Roeckel-Trevisiol N, Crespel A, Balzar J, Schlachter K, Gruber-Sedlmayr U, Pataraia E, Baumgartner C, Zimprich A, Zimprich F, Malafosse A, Szepetowski P (2010) Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures. PLoS One 5(9):e12740. doi:10.1371/journal.pone.0012740
Janszky J, Hoppe M, Clemens Z, Janszky I, Gyimesi C, Schulz R, Ebner A (2005) Spike frequency is dependent on epilepsy duration and seizure frequency in temporal lobe epilepsy. Epileptic Disord 7(4):355–359
Kan AA, de Jager W, de Wit M, Heijnen C, van Zuiden M, Ferrier C, van Rijen P, Gosselaar P, Hessel E, van Nieuwenhuizen O, de Graan PNE (2012) Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines. J Neuroinflammation 9:207. doi:20710.1186/1742-2094-9-207
Keller SS, Mackay CE, Barrick TR, Wieshmann UC, Howard MA, Roberts N (2002) Voxel-based morphometric comparison of hippocampal and extrahippocampal abnormalities in patients with left and right hippocampal atrophy. Neuroimage 16(1):23–31. doi:10.1006/nimg.2001.1072
Kharatishvili I, Immonen R, Grohn O, Pitkanen A (2007) Quantitative diffusion MRI of hippocampus as a surrogate marker for post-traumatic epileptogenesis. Brain 130:3155–3168. doi:10.1093/brain/awm268
Krendl R, Lurger S, Baumgartner C (2008) Absolute spike frequency predicts surgical outcome in TLE with unilateral hippocampal atrophy. Neurology 71(6):413–418. doi:10.1212/01.wnl.0000310775.87331.90
Kuzniecky RI, Bilir E, Gilliam F, Faught E, Palmer C, Morawetz R, Jackson G (1997) Multimodality MRI in mesial temporal sclerosis: relative sensitivity and specificity. Neurology 49(3):774–778
Lee TS, Mane S, Eid T, Zhao H, Lin A, Guan Z, Kim JH, Schweitzer J, King-Stevens D, Weber P, Spencer SS, Spencer DD, de Lanerolle NC (2007) Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes. Mol Med 13(1–2):1–13. doi:10.2119/2006-00079.Lee
Li G, Bauer S, Nowak M, Norwood B, Tackenberg B, Rosenow F, Knake S, Oertel WH, Hamer HM (2011) Cytokines and epilepsy. Seizure 20(3):249–256. doi:10.1016/j.seizure.2010.12.005
Libbey JE, Kirkman NJ, Wilcox KS, White HS, Fujinami RS (2010) Role for complement in the development of seizures following acute viral infection. J Virol 84(13):6452–6460. doi:10.1128/jvi.00422-10
Lucas SM, Rothwell NJ, Gibson RM (2006) The role of inflammation in CNS injury and disease. Brit J Pharmacol 147:S232–S240. doi:10.1038/sj.bjp.0706400
Marchi N, Oby E, Batra A, Uva L, De Curtis M, Hernandez N, Van Boxel-Dezaire A, Najm I, Janigro D (2007) In vivo and in vitro effects of pilocarpine: relevance to ictogenesis. Epilepsia 48(10):1934–1946. doi:10.1111/j.1528-1167.2007.01185.x
Marchi N, Fan Q, Ghosh C, Fazio V, Bertolini F, Betto G, Batra A, Carlton E, Najm I, Granata T, Janigro D (2009) Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 33(2):171–181. doi:10.1016/j.nbd.2008.10.002
Marchi N, Granata T, Freri E, Ciusani E, Ragona F, Puvenna V, Teng Q, Alexopolous A, Janigro D (2011) Efficacy of anti-Inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS One 6(3):e18200. doi:10.1371/journal.pone.0018200
Mathern GW, Babb TL, Vickrey BG, Melendez M, Pretorius JK (1995) The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain 118:105–118. doi:10.1093/brain/118.1.105
Mazzuferi M, Kumar G, Rospo C, Kaminski RM (2012) Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization. Exp Neurol 238(2):156–167. doi:10.1016/j.expneurol.2012.08.022
McDonald CR, Hagler DJ Jr, Ahmadi ME, Tecoma E, Iragui V, Gharapetian L, Dale AM, Halgren E (2008) Regional neocortical thinning in mesial temporal lobe epilepsy. Epilepsia 49(5):794–803. doi:10.1111/j.1528-1167.2008.01539.x
Mueller CJ, Bankstahl M, Groeticke I, Loescher W (2009) Pilocarpine vs. lithium-pilocarpine for induction of status epilepticus in mice: development of spontaneous seizures, behavioral alterations and neuronal damage. Eur J Pharmacol 619(1–3):15–24. doi:10.1016/j.ejphar.2009.07.020
Nakasu Y, Nakasu S, Morikawa S, Uemura S, Inubushi T, Handa J (1995) Diffusion-weighted MR in experimental sustained seizures elicited with kainic acid. Am J Neuroradiol 16(6):1185–1192
Nehlig A (2011) Hippocampal MRI and other structural biomarkers: experimental approach to epileptogenesis. Biomarkers Med 5(5):585–597. doi:10.2217/bmm.11.65
Parekh MB, Carney PR, Sepulveda H, Norman W, King M, Mareci TH (2010) Early MR diffusion and relaxation changes in the parahippocampal gyrus precede the onset of spontaneous seizures in an animal model of chronic limbic epilepsy. Exp Neurol 224(1):258–270. doi:10.1016/j.expneurol.2010.03.031
Paxinos G, Franklin KBJ (2001) The mouse brain In stereotaxic coordinates. Academic Press, New York
Pell GS, Briellmann RS, Waites AB, Abbott DF, Jackson GD (2004) Voxel-based relaxometry: a new approach for analysis of T2 relaxometry changes in epilepsy. Neuroimage 21(2):707–713. doi:10.1016/j.neuroimage.2003.09.059
Pitkanen A (2010) Therapeutic approaches to epileptogenesis-Hope on the horizon. Epilepsia 51:2–17. doi:10.1111/j.1528-1167.2010.02602.x
Pitkanen A, Lukasiuk K (2011) Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 10(2):173–186. doi:10.1016/s1474-4422(10)70310-0
Racine RJ (1972) Modification of seizure activity by electrical stimulation.2. Motor seizure. Electroencephalogr Clin Neurophysiol 32(3):281–294. doi:10.1016/0013-4694(72)90177-0
Rakhade SN, Shah AK, Agarwal R, Yao B, Asano E, Loeb JA (2007) Activity-dependent gene expression correlates with interictal spiking in human neocortical epilepsy. Epilepsia 48:86–95. doi:10.1111/j.1528-1167.2007.01294.x
Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29(1):142–160. doi:10.1016/j.nbd.2007.08.012
Riazi K, Galic MA, Pittman QJ (2010) Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res 89(1):34–42. doi:10.1016/j.eplepsyres.2009.09.004
Roch C, Leroy C, Nehlig A, Namer IJ (2002a) Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats. Epilepsia 43(4):325–335. doi:10.1046/j.1528-1157.2002.11301.x
Roch C, Leroy C, Nehlig A, Namer IJ (2002b) Predictive value of cortical injury for the development of temporal lobe epilepsy in 21-day-old rats: an MRI approach using the lithium-pilocarpine model. Epilepsia 43(10):1129–1136. doi:10.1046/j.1528-1157.2002.17802.x
Rosati A, Aghakhani Y, Bernasconi A, Olivier A, Andermarm F, Gotman J, Dubeau F (2003) Intractable temporal lobe epilepsy with rare spikes is less severe than with frequent spikes. Neurology 60(8):1290–1295
Seiffert E, Dreier JP, Ivens S, Bechmann I, Tomkins O, Heinemann U, Friedman A (2004) Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 24(36):7829–7836. doi:10.1523/jneurosci.1751-04.2004
Shan ZY, Ji Q, Gajjar A, Reddick WE (2005) A knowledge-guided active contour method of segmentation of cerebella on MR images of pediatric patients with medulloblastoma. J Magn Reson Im 21(1):1–11. doi:10.1002/jmri.20229
Sharma AK, Reams RY, Jordan WH, Miller MA, Thacker HL, Snyder PW (2007) Mesial temporal lobe epilepsy: pathogenesis, induced rodent models and lesions. Toxicol Pathol 35(7):984–999. doi:10.1080/01926230701748305
Shibley H, Smith BN (2002) Pilocarpine-induced status epilepticus results in mossy fiber sprouting and spontaneous seizures in C57BL/6 and CD-1 mice. Epilepsy Res 49(2):109–120. doi:10.1016/s0920-1211(02)00012-8
Sloviter RS, Bumanglag AV (2012) Defining “epileptogenesis” and identifying “antiepileptogenic targets” in animal models of acquired temporal lobe epilepsy is not as simple as it might seem. Neuropharmacology. doi:10.1016/j.neuropharm.2012.01.022
Steiner B, Kronenberg G, Jessberger S, Brandt MD, Reuter K, Kempermann G (2004) Differential regulation of gliogenesis in the context of adult hippocampal neurogenesis in mice. Glia 46(1):41–52. doi:10.1002/glia.10337
Tomkins O, Friedman O, Ivens S, Reiffurth C, Major S, Dreier JP, Heinemann U, Friedman A (2007) Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol Dis 25(2):367–377. doi:10.1016/j.nbd.2006.10.006
Ullmann JFP, Keller MD, Watson C, Janke AL, Kurniawan ND, Yang Z, Richards K, Paxinos G, Egan GF, Petrou S, Bartlett P, Galloway GJ, Reutens DC (2012) Segmentation of the C57BL/6J mouse cerebellum in magnetic resonance images. Neuroimage 62(3):1408–1414. doi:10.1016/j.neuroimage.2012.05.061
Uva L, Librizzi L, Marchi N, Noe F, Bongiovanni R, Vezzani A, Janigro D, De Curtis M (2008) Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability. Neuroscience 151(1):303–312. doi:10.1016/j.neuroscience.2007.10.037
van Gassen KLI, de Wit M, Koerkamp MJAG, Rensen MGA, van Rijen PC, Holstege FCP, Lindhout D, de Graan PNE (2008) Possible role of the innate immunity in temporal lobe epilepsy. Epilepsia 49(6):1055–1065. doi:10.1111/j.1528-1167.2007.01470.x
VanLandingham KE, Heinz ER, Cavazos JE, Lewis DV (1998) Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol 43(4):413–426. doi:10.1002/ana.410430403
Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Julio Rodriguez J, Nedergaard M (2012) Neurological diseases as primary gliopathies: a reassessment of neurocentrism. Asn Neuro 4 (3). doi:10.1042/an20120010
Vezzani A, Granata T (2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46(11):1724–1743. doi:10.1111/j.1528-1167.2005.00298.x
Vezzani A, Balosso S, Ravizza T (2008a) The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22(6):797–803. doi:10.1016/j.bbi.2008.03.009
Vezzani A, Ravizza T, Balosso S, Aronica E (2008b) Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 49:24–32. doi:10.1111/j.1528-1167.2008.01490.x
Vezzani A, Aronica E, Mazarati A, Pittman QJ (2011a) Epilepsy and brain inflammation. Exp Neurol. doi:10.1016/j.expneurol.2011.09.033
Vezzani A, French J, Bartfai T, Baram TZ (2011b) The role of inflammation in epilepsy. Nat Rev Neurol 7(1):31–40. doi:10.1038/nrneurol.2010.178
Vezzani A, Maroso M, Balosso S, Sanchez M-A, Bartfai T (2011c) IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 25(7):1281–1289. doi:10.1016/j.bbi.2011.03.018
Wall CJ, Kendall EJ, Obenaus A (2000) Rapid alterations in diffusion-weighted images with anatomic correlates in a rodent model of status epilepticus. Am J Neuroradiol 21(10):1841–1852
Wang Y, Majors A, Najm I, Xue M, Comair Y, Modic M, Ng TC (1996) Postictal alteration of sodium content and apparent diffusion coefficient in epileptic rat brain induced by kainic acid. Epilepsia 37(10):1000–1006. doi:10.1111/j.1528-1157.1996.tb00539.x
Weissberg I, Reichert A, Heinemann U, Friedman A (2011) Blood-brain barrier dysfunction in epileptogenesis of the temporal lobe. Epilepsy Res Treat 2011:143908. doi:10.1155/2011/143908
White HS (2002) Animal models of epileptogenesis. Neurology 59(9):S7–S14
Winawer MR, Makarenko N, McCloskey DP, Hintz TM, Nair N, Palmer AA, Scharfman HE (2007) Acute and chronic responses to the convulsant pilocarpine in DBA/2J and A/J mice. Neuroscience 149(2):465–475. doi:10.1016/j.neuroscience.2007.06.009
Wuerfel E, Infante-Duarte C, Glumm R, Wuerfel JT (2010) Gadofluorine M-enhanced MRI shows involvement of circumventricular organs in neuroinflammation. J Neuroinflammation 7. doi:10.1186/1742-2094-7-70
Acknowledgments
We would like to thank the National Imaging Facility (NIF) and the Queensland NMR Network (QNN) for access to the 16.4 T scanner and technical support. We thank Australian Mouse Brain Mapping Consortium for providing an atlas for image registration. We express our gratitude to Dr. Karin Borges for advice in establishing a mouse pilocarpine model, and to Mr. Luke Hammond and Ms Jane Ellis from Queensland Brain Institute for technical advice and assistance. This project was funded by the National Health and Medical Research Council (NHMRC) of Australia (to D.C.R) and the University of Queensland New Staff Research Start Up Grant (to I.K.).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
429_2013_528_MOESM1_ESM.tif
Supplementary figure 1 Receiver observed curves (ROC) for ADC changes in the ventral hippocampus assessed at 7 days after status epilepticus, which predicted severity of epileptic condition (i.e. increase in spike frequency) in the chronic stage. The area under the curve (AUC) for ROC curve is 0.93 indicating high predictive accuracy of ADC values (TIFF 10974 kb)
429_2013_528_MOESM2_ESM.tif
Supplementary figure 2 Distribution of GFAP (A1, B1, C1) and C3 (A2, B2, C2) immunoreactivity in the septal hippocampus 3 months after pilocarpine-induced status epilepticus in the 3 SE mice with interictal spiking on EEG but no spontaneous seizures. Note reactive astrogliosis and prominent increased expression of C3 in astrocytes in the hilus and granule cell layer of the dentate gyrus, as well as ablation of CA1 in animals #20 and #37. Animal #66 did not demonstrate severe astrogliosis or hippocampal atrophy, but had increased levels of C3 expression in astrocytes forming continuous band in the subgranular zone. Scale bar in all panels 100µm (TIFF 10196 kb)
429_2013_528_MOESM3_ESM.tif
Supplementary figure 3 Volumetric MRI data and a ROI-based analysis of the dynamics of hippocampal ADC and T2 changes in the animals with spikes + SRS and those with spikes only. The quantitative data from individual animals are presented as scatterplots. Closed circles refer to animals with spontaneous recurrent seizures and open circles to 3 animals with spikes only. Animals in Group 1 were imaged at 3 hours and 7, 28 and 49 days after pilocarpine injection and in Group II at 1, 2, 14 and 35 days after pilocarpine injection. The results show that the 2 animals with more severe hippocampal sclerosis observed in histological sections (#20, #37, Group 1) had more severe hippocampal damage on MRI, and the third animal (#66, Group 2, D-F) had less severe damage compared to the group of animals with SRS. Severity of hippocampal damage is reflected by a decrease in relative hippocampal volumes (A) and gradual increase in the hippocampal ADC and T2 values during follow-up time (B,C), above the group mean from animals with SRS (TIFF 17536 kb)
Rights and permissions
About this article
Cite this article
Kharatishvili, I., Shan, Z.Y., She, D.T. et al. MRI changes and complement activation correlate with epileptogenicity in a mouse model of temporal lobe epilepsy. Brain Struct Funct 219, 683–706 (2014). https://doi.org/10.1007/s00429-013-0528-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00429-013-0528-4